Literature DB >> 12544223

Porous polymethylmethacrylate as bone substitute in the craniofacial area.

Marco L Bruens1, Herman Pieterman, Joost R de Wijn, J Michael Vaandrager.   

Abstract

In craniofacial surgery, alloplastic materials are used for correcting bony defects. Porous polymethylmethacrylate (PMMA) is a biocompatible and nondegradable bone cement. Porous PMMA is formed by the classic bone cement formulation of methylmethacrylate liquid and PMMA powder in which an aqueous biodegradable carboxymethylcellulose gel is dispersed to create pores in the cement when cured. Pores give bone the opportunity to grow in, resulting in a better fixation of the prostheses. We evaluated the long-term results (n = 14), up to 20 years, of augmentations and defect fillings in the craniofacial area, with special interest in possible side effects and bone ingrowth. The evaluation consisted of a questionnaire, a physical examination, and a computed tomography (CT) scan. There were no side effects that could be ascribed to the porous PMMA. Twelve CT scans showed bone ingrowth into the prostheses, proving the validity behind the concept of porous PMMA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544223     DOI: 10.1097/00001665-200301000-00011

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  15 in total

1.  Reconstruction of bony facial contour deficiencies with polymethylmethacrylate implants: case report.

Authors:  Ruy C C Abdo Filho; Thais M Oliveira; Natalino Lourenço Neto; Carla Gurgel; Ruy C C Abdo
Journal:  J Appl Oral Sci       Date:  2011-08       Impact factor: 2.698

Review 2.  Craniofacial tissue engineering by stem cells.

Authors:  J J Mao; W V Giannobile; J A Helms; S J Hollister; P H Krebsbach; M T Longaker; S Shi
Journal:  J Dent Res       Date:  2006-11       Impact factor: 6.116

3.  Cranioplasty in children.

Authors:  V A Josan; S Sgouros; A R Walsh; M S Dover; H Nishikawa; A D Hockley
Journal:  Childs Nerv Syst       Date:  2004-12-23       Impact factor: 1.475

4.  Evaluation of soft tissue coverage over porous polymethylmethacrylate space maintainers within nonhealing alveolar bone defects.

Authors:  James D Kretlow; Meng Shi; Simon Young; Patrick P Spicer; Nagi Demian; John A Jansen; Mark E Wong; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part C Methods       Date:  2010-06-04       Impact factor: 3.056

5.  In situ formation of porous space maintainers in a composite tissue defect.

Authors:  Patrick P Spicer; James D Kretlow; Allan M Henslee; Meng Shi; Simon Young; Nagi Demian; John A Jansen; Mark E Wong; Antonios G Mikos; F Kurtis Kasper
Journal:  J Biomed Mater Res A       Date:  2012-01-12       Impact factor: 4.396

6.  Basic fibroblast growth factor inhibits osteogenic differentiation of stem cells from human exfoliated deciduous teeth through ERK signaling.

Authors:  B Li; C Qu; C Chen; Y Liu; K Akiyama; R Yang; F Chen; Y Zhao; S Shi
Journal:  Oral Dis       Date:  2011-12-12       Impact factor: 3.511

7.  Sutures Possess Strong Regenerative Capacity for Calvarial Bone Injury.

Authors:  Shery Park; Hu Zhao; Mark Urata; Yang Chai
Journal:  Stem Cells Dev       Date:  2016-10-24       Impact factor: 3.272

Review 8.  Current concepts of bone tissue engineering for craniofacial bone defect repair.

Authors:  Brian Alan Fishero; Nikita Kohli; Anusuya Das; John Jared Christophel; Quanjun Cui
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-18

9.  Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control.

Authors:  Meng Shi; James D Kretlow; Anson Nguyen; Simon Young; L Scott Baggett; Mark E Wong; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomaterials       Date:  2010-02-13       Impact factor: 12.479

10.  Surface modification of fiber reinforced polymer composites and their attachment to bone simulating material.

Authors:  M P Hautamäki; M Puska; A J Aho; H M Kopperud; P K Vallittu
Journal:  J Mater Sci Mater Med       Date:  2013-02-26       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.